Top Personalized Nutrition Companies

The personalized nutrition market is estimated to be USD 15.79 billion in 2025 and is projected to reach USD 30.94 billion by 2030, at a CAGR of 14.4% from 2025 to 2030. The application landscape of this market is diverse, with demand fueled by both preventive and performance-oriented goals. Among key areas, the weight management & metabolic health segment continues to dominate due to the rising prevalence of obesity, diabetes, and lifestyle-related disorders, making it a cornerstone of personalized diet plans and supplement programs. Sports & fitness performance is expanding steadily, driven by fitness-conscious millennials and the integration of wearables that track activity and recovery. Meanwhile, the clinical nutrition & disease management segment is gaining momentum as healthcare systems shift toward preventive and patient-specific solutions. Emerging segments like beauty, skin, & longevity are witnessing fast-paced growth, supported by strong consumer interest in holistic wellness, anti-aging, and nutricosmetics. Overall, the application spectrum is evolving from broad lifestyle approaches to highly specialized, science-backed solutions tailored to individual needs, positioning the market for robust long-term growth.

Some of the major players in the personalized nutrition market are Abbott (US), Nestlé Health Science (Switzerland), Medtronic (Ireland), 23andMe (US), Prenetics (Hong Kong), ZOE (UK), Viome (US), and InsideTracker (US). These players have incorporated various organic and inorganic growth strategies, including collaborations, acquisitions, product launches, partnerships, agreements, and expansions, to strengthen their international footprint and capture a greater share of the personalized nutrition market.

To know about the assumptions considered for the study download the pdf brochure

Abott (US)

Abbott, a global healthcare leader headquartered in Illinois, US, has a diversified nutrition and diagnostics portfolio that positions it strategically in the personalized nutrition market. Its FreeStyle Libre continuous glucose monitoring (CGM) system is a major enabler of personalized nutrition, empowering individuals with diabetes and wellness users to tailor diet and lifestyle choices in real time. Abbott recently extended this technology with Lingo, marketed toward broader metabolic health, demonstrating how the company is pushing CGMs beyond disease management into lifestyle personalization. On the nutrition side, Abbott offers products such as Ensure, Glucerna, and Pediasure, which, while not inherently personalized, are increasingly integrated into condition-specific dietary plans supported by digital tools and healthcare providers. The company benefits from its strong clinical credibility, regulatory expertise, and global distribution, but its exposure to personalized nutrition remains a small fraction of its overall USD 40 billion+ revenues. Abbott’s personalized nutrition positioning is more “enabler-driven” (via devices and clinical nutrition) rather than direct-to-consumer customization.

Nestlé Health Science (Switzerland)

Nestlé Health Science (NHSc), headquartered in Vevey, Switzerland, is the specialized health arm of Nestlé, focusing on medical nutrition, consumer health products, and science-driven supplements. NHSc has become one of the largest corporate investors in personalized nutrition, expanding aggressively through acquisitions and partnerships. The purchase of Persona Nutrition (personalized vitamin subscription packs) and brands like Garden of Life, Vital Proteins, and Pure Encapsulations has given NHSc a strong footprint in the supplements and wellness categories. While the broader Nestlé group generates over CHF 90B annually, NHSc contributes around CHF 6–7B, with personalized nutrition forming a fast-growing but relatively small sub-segment. Unlike startups, NHSc leverages global distribution, clinical validation, and R&D capacity, giving it an edge in scaling personalization through established supplement brands and healthcare channels. Nestlé has also invested in digital health collaborations, integrating genetics, diagnostics, and apps with product delivery, though execution remains early-stage. Its strategy clearly emphasizes premiumization and science-backed personalization, appealing to both direct consumers and healthcare providers.

ZOE (UK)

ZOE, headquartered in London, UK, is one of the most prominent personalized nutrition startups globally, focusing on microbiome, biomarker, and wearable integration to provide individualized diet recommendations. Emerging from the PREDICT studies, one of the largest ongoing nutrition science programs, ZOE differentiates itself with strong clinical and scientific credibility, using data from microbiome sequencing, blood fat/glucose tests, and real-time monitoring. Its subscription-based model delivers an app-driven nutrition program, which has gained rapid consumer adoption in the UK and US, with estimates of over 100,000 subscribers by 2024. ZOE’s proposition resonates with consumers seeking more than supplements — offering actionable dietary guidance grounded in science. The company has successfully positioned itself at the intersection of digital health and consumer nutrition, supported by collaborations with leading academic institutions, such as King’s College London. Financially, ZOE remains venture-backed, with revenues likely in the USD 100–200 million range, placing it among the top private players in the field. Its key strengths include a robust scientific brand, strong community engagement, and a platform business model that can scale globally.

Market Ranking

The personalized nutrition market is fragmented, with the top five players collectively holding less than 15% of the total market share, indicating significant space for both startups and incumbents. Companies are actively pursuing strategic partnerships, product innovations, and digital integrations to strengthen their positions. The landscape is driven by consumer demand for data-driven wellness solutions, spanning from customized supplements and probiotics to AI-driven apps and diagnostic testing. For example, in March 2024, ZOE announced its expansion into the US corporate wellness sector, partnering with several large employers to integrate microbiome testing and AI-driven dietary coaching into workplace health programs. This move demonstrates how leading players are scaling from direct-to-consumer channels into institutional partnerships to broaden adoption. Similarly, Viome secured FDA Breakthrough Designation in 2023 for its RNA-based saliva test, positioning it not only as a nutrition company but also as a health-tech innovator with applications in disease risk assessment.

Related Reports:

Personalized Nutrition Market by Product (Products, Services, Digital Tools), Application (General Lifestyle, Beauty, Skin & Longevity, Weight Management & Metabolic Health), End-use, Personalization Basis, Type, & Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets Inc.
1615 South Congress Ave.
Suite 103,
Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com